Global Tissue Diagnostics Market 2019-2022 | 6.9% CAGR Projection over the Next Five Years
The tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%.
(businesspress24) - The tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%.
Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics.
In this report, the Tissue Diagnostics market has been segmented based on product, technology, disease, end user, and region.
What the Market Looks Like?
The Report & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022
Download a FREE Pdf Brochuer(at):- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949
Consumables are estimated to account for the largest market share in 2017
By product, the tissue diagnostics market is classified into instruments and consumables. The consumables segment is expected to lead the global tissue diagnostics market in 2017. Factors driving the growth of this segment include the wide use of consumables for processing tissue samples, ease of use, and cost-effectiveness.
The immunohistochemistry segment is expected to dominate the market in 2017
By technology, the market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry technology segment is expected to account for the largest share of the global tissue diagnostics market in 2017. A large number of products are based on this technology which is a major factor responsible for the dominant share of this segment.
The Major Players Opearting in the Tissue Diagnostics Market:
Key players in the Tissue Diagnostics Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagn
Get a FREE Request Sample Report(at):-https://www.marketsandmarkets.com/requestsampleNew.asp?id=9571619
Geographical Detailed Analysis for Tissue Diagnostics Market:
The global tissue diagnostics market is dominated by North America, followed by Europe.
North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.
Themen in dieser Pressemitteilung:
tissue-diagnostics-market-growth
tissue-diagnostics-market-share
tissue-diagnostics-market-size
tissue-diagnostics-market-trends
global-tissue-diagnostics-market
tissue-diagnostics-asia-pacific-market
tissue-diagnostics-europe-market
tissue-diagnos
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 23.07.2019 - 11:18 Uhr
Sprache: Deutsch
News-ID 1537163
Anzahl Zeichen: 3428
Kontakt-Informationen:
Ansprechpartner: Mr. Shelly Singh
Stadt:
northbrook
Telefon: 8886006441
Kategorie:
Vermischtes
Meldungsart: bitte
Versandart: Veröffentlichung
Freigabedatum:
Anmerkungen:
Diese Pressemitteilung wurde bisher 92 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Tissue Diagnostics Market 2019-2022 | 6.9% CAGR Projection over the Next Five Years
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
